Recombinant proteins for therapy

Trends in Pharmacological Sciences

Volumn 17, Issue 12, 1996, Pages 450-456

  Buckel, Peter ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

GENE THERAPY; GENERAL ASPECTS OF DISEASE; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030462001     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01011-5     Document Type: Review

References (31)

1. 1 Cohen, S., Chang, A. C. Y., Boyer, H. W. and Helling, R. B. (1973) Proc. Natl. Acad. Sci. U. S. A. 70, 3240-3244
2. 2 Johnson, J. S. (1983) Science 219, 632-637
3. 3 Anon. (1996) SCRIP 2096, 11
4. 4 Mossinghoff, G. J. in Biotechnology in Development Medicines (PhRMA, eds), pp. 1-24, own press
5. 5 DiMasi, J. A., Hansen, R. W., Grabowski, H. G. and Lasagna, L. (1991) J. Health Econom. 10, 107-142
6. 6 Bienz-Tadmor, B., Dicerbo, P. A., Tadmor, G. and Lasagna, L. (1992) Biotechnology 10, 521-525
7. 7 Struck, M-M. (1994) Biotechnology 12, 674-677
8. 8 Krantz, S. B., Sawyer, S. T. and Sawada, K-J. (1988) Contr. Nephrol. 66, 25-37
9. 9 Scigalla, P., Wieczorek, L. and Bicker, U. (1990) in Erythropoietin in Clinical Applications (Garnick, M. B., ed.), pp. 141-182, Marcel Dekker
10. 10 Mark, D. F., Lu, S. D., Creasey, A. A., Yamamoto, R. Y. and Lin, L. S. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 5662-5666
11. 11 Walker, P. A. et al. (1994) Biotechnology 12, 601-605
12. 12 Topol, E. et al. (1987) J. Am. Coll. Cardiol. 9, 1205-1213
13. 13 Harris, T. J. R. (1987) Protein Eng. 1, 449-458
14. 14 Patthy, L. (1985) Cell 41, 657-663
15. 15 Kohnert, U. et al. (1992) Protein Eng. 5, 93-100
16. 16 Kohnert, U., Horsch, B. and Fischer, S. (1993) Fibrinolysis 7, 365-372
17. 17 Seifried, E., Müller, M., Martin, U., König, R. and Hombach, V. (1991) Ann. New York Acad. Sci. 667, 417-420
18. 18 Smalling, R. W. et al. (1995) Circulation 91, 2725-2732
19. 19 Wilcox, R. G. (1995) Lancet 346, 329-336
20. 20 Capon, D. J. et al. (1989) Nature 337, 525-530
21. 21 Winter, G. and Milstein, C. (1991) Nature 349, 293-299
22. 22 Vitetta, E. (1994) J. Immunol. 153, 1407-1420
23. 23 Brinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M. and Pastan, I. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 8616-8620
24. 24 Pastan, I. et al. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2765-2769
25. 25 Anderson, F. W. (1995) Sci. Am. 9, 96-98
26. 26 Anderson, F. W. (1996) Hum. Gene Ther. 7, 568-587
27. 27 Günzburg, W. H. and Salmons, B. (1995) Mol. Med. Today 1, 410-417
28. 28 Unterhuber, R. (1996) Nat. Med. 2, 136
29. 29 Grindley, J. N. and Ogden, J. E. (1995) Scrip Mag. 11, 53-56
30. 30 Ashton, J. M., Jaye, M. C. and Mason, J. S. (1996) Drug Discovery Today 1, 11-15
31. 31 Ashton, J. M., Jaye, M. C. and Mason, J. S. (1996) Drug Discovery Today 1, 71-78